Patient characteristics and the effects of intravenous immunoglobulin in patients with Guillain-Barre syndrome = Az intravénás immunglobulin-kezelés hatásai és a betegek jellemzői Guillain-Barré-szindrómában
| Autor: | Belma Doğan Güngen, Osman Tanik, Yeşim Güzey Aras, Dilcan Kotan |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Rehabilitation biology Guillain-Barre syndrome business.industry medicine.medical_treatment Patient characteristics medicine.disease Intensive care unit law.invention Neurology Functional grading law Internal medicine Intensive care biology.protein Medicine In patient Neurology (clinical) Antibody business |
| Zdroj: | Ideggyógyászati Szemle. 69 |
| ISSN: | 0019-1442 |
| DOI: | 10.18071/isz.69.0389 |
| Popis: | Purpose - The purpose of this study is to determine the diagnosis- and treatment-related characteristics in Guillain-Barre syndrome (GBS) and to evaluate the effects of early intravenous immunoglobulin (IVIg) treatment on disability, mortality and prognosis. Materials and methods - Adult patients who were diagnosed with GBS in our clinic between January 2000 and January 2014 were retrospectively scanned. While the patients undergoing IVIg treatment were included in the study, the other neuropathic diseases were excluded. Patients were divided into two groups based on the administration time of the IVIg treatment; Group 1 ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|